Embark
ClosedKnow your dog. Better.
Boston, United States · Founded 2015 · $91.1M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2C
- Website
- letsembark.com
- Total Funding
- $91.1M
- Last Round
- $75.0M Series BJul 2021
- Rounds
- 4
About
Embark Veterinary is a canine genomics and biotechnology company based in Boston, Massachusetts, founded in 2015 by brothers Adam and Ryan Boyko. The company offers dog DNA testing services to consumers, breeders, and veterinary practices. Its flagship products screen for over 400 dog breeds and test for hundreds of genetic health conditions, coat color and trait markers, estimated biological age, and a Relative Finder feature that connects dogs sharing DNA. Embark uses a research-grade microarray platform developed in partnership with Cornell University College of Veterinary Medicine, making it one of the most scientifically rigorous consumer dog DNA tests available. The company also offers gut health tests and targeted nutritional supplements. Embark has helped millions of pet parents better understand their dogs' breed ancestry, health risks, and care needs.
Summary
Embark is a Biotech company based in Boston, United States, founded in 2015. It has raised $91.1M in total across 4 rounds, most recently a $75.0M Series B round in Jul 2021. Investors include Slow Ventures, F-Prime Capital and SoftBank.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2021
Sign up to see all 4 rounds
Seed through Series B — per-round amounts, valuations, and who invested in each round.
Investors
.png)
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/embark"><img src="https://indexed.vc/api/badge/company/embark" alt="Embark on Indexed.vc" width="260" height="76" /></a>